|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Targeting the PI3K-AKT-mTOR pathway:progress,pitfalls,and promises显示文摘 | Yap TA Garrett MD Walton MI | | 0，，： | 1 |
| 2 | Targeting the PI3K-AKTmTORpathway:progress,pitfalls,and promises显示文摘 | Yap TA Garrett MD Walton MI | | 0，，04： | 1 |
| 3 | Targeting the PI3K - AKT - mTOR pathway: progress, pitfalls, and promises 显示文摘 | Yap TA Garrett MD Walton MI | 2008 | Curr Opin Pharmaeol2008，8，： | 1 |
| 4 | Expression cloning of three Rhizobium leguminosarum lipopolysaccharide core galacturonosyltransferases显示文摘 | Kanjilal-Kolar S Basu SS Kanipes MI Guan Z Garrett TA Raetz CR | | 0，，： | 1 |
| 5 | VEGF-induced rZacl acti- vation in endothelial cells is regulated by the guanine nucleotide ex- change factor Vav2显示文摘 | Garrett TA Van Buul JD Burridge K | 2007 | Exp Cell Res2007，313，15： | 1 |
| 6 | Targeting the PI3K-AKT-mTOR pathway:progress,pitfal s,and promises显示文摘 | Yap TA Garrett MD Walton MI | | 0，，04： | 1 |
| 7 | Targeting the PI3K- AKT-mTOR pathway: progress, pitfalls, and promises 显示文摘 | Yap TA Garrett MD Walton MI | 2008 | Current Opinion in Pharmacology2008，8，4： | 1 |
| 8 | Targetingthe PI3 K-AKT-mTOR pathway:progress,pitfalls,and promises显示文摘 | Yap TA Garrett MD Walton MI | | 0，，04： | 1 |
| 9 | Targeting the PI3K- AKT-mTOR pathway: progress, pitfalls, and promises 显示文摘 | Yap TA Garrett MD Walton MI | 2008 | Curr Opin Pharmacol2008，8，4： | 1 |
| 10 | Bacillus subtilis protease: a new topical agent for debridement 显示文摘 | Garrett TA | 1969 | Clin Med1969，76，5： | 1 |
| 11 | Mice with a targeted mutation in the thyroid hormone beta receptor gene exhibit impaired growth and resistance to thyroid hormone显示文摘 | Kaneshige M Kaneshige K Zhu X Dace A Garrett L Carter TA Kazlauskaite R Pankratz DG Wynshaw-Boris A Refetoff S Weintraub B Willingham MC Barlow C Cheng S | | 0，，： | 1 |
| 12 | Targeting the PI3K-AKT-mTOR pathway:progress,pitfalls,and promises显示文摘 | Yap TA Garrett MD Walton MI | 2008 | Curr Opin Pharmacol2008，8，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员